(B) epidemiology; 
(C) medicine; 
(D) emergency management or response; 
(E) public administration; 
(F) logistics; 
(G) organizational management; or 
(H) medical intelligence and forensic inves-
tigations; and 
(5) it is crucial to better understand and man-
age the increasing likelihood of pandemic threats 
(such as the recent threats of severe acute res-
piratory syndrome (SARS), Ebola, the 2009–H1N1 
influenza, and COVID–19) and related health issues 
that the United States could face during the next 
several decades. 
SEC. 2. COMMISSION ON THE COVID–19 PANDEMIC. 
(a) ESTABLISHMENT OF COMMISSION.—There is es-
tablished in the legislative branch the National Commis-
sion on the COVID–19 Pandemic (in this section referred 
to as the ‘‘Commission’’). 
(b) DUTIES.—The Commission shall— 
(1) in accordance with subsection (d), conduct 
an investigation of all relevant facts and cir-
cumstances regarding the novel coronavirus disease 
2019 (in this section referred to as ‘‘COVID–19’’) 
VerDate Sep 11 2014 
16:51 Mar 15, 2022
Jkt 029200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H7069.IH
H7069
pamtmann on DSKBC07HB2PROD with BILLS
in order to make a full and complete accounting 
of— 
(A) the preparedness of the United States 
for pandemic disease before the outbreak of 
COVID–19; 
(B) the circumstances surrounding the ini-
tial outbreak and spread of COVID–19; and 
(C) the actions taken by the Federal Gov-
ernment, State, local, and Tribal governments, 
including with respect to the private sector, civil 
society, and relevant international organizations 
(including the World Health Organization) in 
response to COVID–19; 
(2) identify and examine lessons learned regard-
ing pandemic preparedness, response, and recovery 
efforts by the Federal Government and State, local, 
and Tribal governments, and international partners; 
and 
(3) submit to the President and Congress, and 
make publicly available, such reports as are required 
by this section containing findings, conclusions, and 
recommendations as the Commission determines ap-
propriate to improve the ability of the United States 
to prepare for, detect, prevent, and, if necessary, re-
spond to and recover from epidemics and pandemics 
VerDate Sep 11 2014 
16:51 Mar 15, 2022
Jkt 029200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H7069.IH
H7069
pamtmann on DSKBC07HB2PROD with BILLS
such as COVID–19 (whether naturally occurring or 
caused by State or non-State actors) in a way that 
minimizes negative effects on public health, the 
economy, and society. 
(c) COMPOSITION OF COMMISSION.— 
(1) MEMBERS.—The Commission shall be com-
posed of 10 members, of whom— 
(A) 1 member shall be appointed by the 
President, who shall serve as chair of the Com-
mission; 
(B) 1 member shall be appointed by the 
leader of the House of Representatives (the 
Speaker or minority leader, as the case may be) 
of the political party that is not the same polit-
ical party as the President, in consultation with 
the leader of the Senate (majority or minority 
leader, as the case may be) of the same political 
party as such leader of the House of Represent-
atives, who shall serve as vice chair of the Com-
mission; 
(C) 2 members shall be appointed by the 
senior member of the Senate leadership of the 
Democratic Party; 
VerDate Sep 11 2014 
16:51 Mar 15, 2022
Jkt 029200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H7069.IH
H7069
pamtmann on DSKBC07HB2PROD with BILLS